Profusa (PFSA) Operating Income (2022 - 2026)
Profusa's (PFSA) quarterly Operating Income came in at -$4.0 million in Q1 2026, down 181.32% year-on-year from $4.9 million in Q1 2025, and down 12.21% quarter-over-quarter from -$3.6 million in Q4 2025.
Profusa (PFSA) Operating Income (2022 - 2026) Analysis & Trends
Profusa's Operating Income history runs 5 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- On a quarterly basis, Operating Income fell 181.32% year-over-year to -$4.0 million in Q1 2026; TTM through Mar 2026 was -$30.3 million, a 683.3% decrease from a year earlier, with the FY2025 full-year figure at -$27.7 million, down 515.69% from the prior year.
- Operating Income fell to -$4.0 million in Q1 2026 per PFSA's latest filing, from -$3.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$217525.0 in Q2 2022 and bottomed at -$21.7 million in Q3 2025.
- The 5-year median for Operating Income is -$460158.0 (2023), against an average of -$2.2 million.
- Across the five-year window, Operating Income advanced 28.27% in 2023 and plunged 1868.18% in 2025, its largest moves.
- Year by year, Operating Income stood at -$407008.0 in 2022, then slipped by 13.06% to -$460158.0 in 2023, then sank by 135.14% to -$1.1 million in 2024, then plunged by 229.94% to -$3.6 million in 2025, then slipped by 12.21% to -$4.0 million in 2026.
- Per Business Quant, the three latest PFSA Operating Income figures stand at -$4.0 million (Q1 2026), -$3.6 million (Q4 2025), and -$21.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | -4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.01 Mn |
| Dec 31, 2025 | -3.57 Mn |
| Sep 30, 2025 | -21.71 Mn |
| Jun 30, 2025 | -967,084.00 |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -1.10 Mn |
| Jun 30, 2024 | -253,130.00 |
| Mar 31, 2024 | -470,841.00 |
| Dec 31, 2023 | -460,158.00 |
| Sep 30, 2023 | -290,098.00 |
| Jun 30, 2023 | -314,710.00 |
| Mar 31, 2023 | -443,717.00 |
| Dec 31, 2022 | -407,008.00 |
| Sep 30, 2022 | -404,425.00 |
| Jun 30, 2022 | -217,525.00 |
| Mar 31, 2022 | -241,596.00 |